ClinicalTrials.Veeva

Menu

A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211) (FACT)

Organon logo

Organon

Status and phase

Completed
Phase 3

Conditions

Postmenopausal Osteoporosis

Treatments

Dietary Supplement: Vitamin D
Drug: Alendronate placebo
Drug: Risedronate 35 mg
Drug: Risendronate placebo
Drug: Alendronate
Dietary Supplement: Elemental Calcium

Study type

Interventional

Funder types

Industry

Identifiers

NCT00092014
0217-211
2004_016 (Other Identifier)

Details and patient eligibility

About

This study is to evaluate and compare the effects of Alendronate and Risedronate to treat women with postmenopausal osteoporosis. The primary hypothesis for this study is that in postmenopausal women with osteoporosis, treatment with oral alendronate 70 mg once weekly will produce a mean percent increase from baseline in hip trochanter bone mineral density (BMD) at 12 and 24 months which is greater than that observed with oral risedronate 35 mg once weekly.

Enrollment

1,053 patients

Sex

Female

Ages

25+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women with postmenopausal osteoporosis

Exclusion criteria

  • Bilateral hip replacements
  • Esophageal abnormalities
  • Metabolic bone disease (example - Vitamin D deficiency)
  • Medications that would affect the breakdown or build-up of bone turnover

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

1,053 participants in 2 patient groups

Alendronate 70 mg
Experimental group
Description:
Alendronate sodium, 70 mg, orally once weekly for up to 24 months
Treatment:
Dietary Supplement: Elemental Calcium
Drug: Risendronate placebo
Drug: Alendronate
Dietary Supplement: Vitamin D
Risendronate 35 mg
Active Comparator group
Description:
Risendronate, 35 mg, orally once weekly for up to 24 months
Treatment:
Dietary Supplement: Elemental Calcium
Drug: Risedronate 35 mg
Drug: Alendronate placebo
Dietary Supplement: Vitamin D

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems